Sustainably reducing device utilization and device-related infections with DeCATHlons, device alternatives, and decision support.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 1 7 2020
medline: 26 8 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

Engagement of frontline staff, along with senior leadership, in competition-style healthcare-associated infection reduction efforts, combined with electronic clinical decision support tools, appeared to reduce antibiotic regimen initiations for urinary tract infections (P = .01). Mean monthly standardized infection and device utilization ratios also decreased (P < .003 and P < .0001, respectively).

Identifiants

pubmed: 32600491
pii: S0899823X20002950
doi: 10.1017/ice.2020.295
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1344-1347

Auteurs

Emil P Lesho (EP)

Infectious Diseases Unit, Rochester Regional Health, Rochester, New York.

Robert Clifford (R)

Bioinformatics, Cavia Partners, Silver Spring, Maryland.

Kelly Vore (K)

Infection Prevention, Rochester Regional Health, Rochester, New York.

Balazs Zsenits (B)

Health Informatics, Rochester Regional Health, Rochester, New York.

Jose Alcantara (J)

Health Informatics, Rochester Regional Health, Rochester, New York.

Bryan Gargano (B)

Associate Chief Medical Officer, Rochester Regional Health, Rochester, New York.

Matthew Phillips (M)

Health Informatics, Rochester Regional Health, Rochester, New York.

Susan Boyd (S)

Nursing, Rochester Regional Health, Rochester, New York.

Laura Eckert-Davis (L)

Nursing, University of Rochester Medical Center, Rochester, New York.

Carlos Sosa (C)

Infection Prevention, Rochester Regional Health, Rochester, New York.

Roberto Vargas (R)

Pathology Department, Rochester Regional Health, Rochester, New York.

Dawn Riedy (D)

Pathology Department, Rochester Regional Health, Rochester, New York.

Deborah Stamps (D)

Quality and Safety Institute, Rochester Regional Health, Rochester, New York.

Hiloni Bhavsar (H)

Quality and Safety Institute, Rochester Regional Health, Rochester, New York.

Jennifer Fede (J)

Infection Prevention, Rochester Regional Health, Rochester, New York.

Maryrose Laguio-Vila (M)

Infectious Diseases Unit, Rochester Regional Health, Rochester, New York.

Melissa Bronstein (M)

Quality and Safety Institute, Rochester Regional Health, Rochester, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH